IPP Bureau
Matt Sause elevated as new CEO of Roche Diagnostics
By IPP Bureau - October 04, 2022
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Moderna creates new executive committee role for product launches
By IPP Bureau - October 04, 2022
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav
By IPP Bureau - October 03, 2022
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Lupin gets EIR from USFDA for its Ankleshwar facility
By IPP Bureau - October 03, 2022
The inspection of the facility was conducted from August 16-19, 2022.
SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru
By IPP Bureau - October 03, 2022
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences
By IPP Bureau - October 03, 2022
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Lupin Life announces association with Vikram Vedha as official energy partner
By IPP Bureau - October 02, 2022
Enriched with eight ayurvedic active ingredients like Ashwagandha, Shilajit, Shatavari, and Pippali, Be One works holistically to provide energy, build immunity and enable a healthy body and mind
Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister
By IPP Bureau - October 01, 2022
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
Dr VK Paul delivers lecture at NITI Aayog’s First India Development Strategies Lecture Series
By IPP Bureau - October 01, 2022
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Philips shareholders appoint Roy Jakobs as next President and CEO
By IPP Bureau - October 01, 2022
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData
By IPP Bureau - October 01, 2022
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Zydus receives final approval from the USFDA for Sildenafil for Oral Suspension
By IPP Bureau - October 01, 2022
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
USFDA inspects Zydus Lifesciences Ahmedabad SEZ facility
By IPP Bureau - September 30, 2022
The company will address the observations within a stipulated timeline working with the regulators
Lupin receives US FDA approval for Mirabegron Extended-Release tablets
By IPP Bureau - September 30, 2022
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
Lupin receives warning letter from US FDA
By IPP Bureau - September 30, 2022
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
